BioDiscovery Announces Distribution Agreement with UBI

to increase presence in Canadas growing microarray market.

Marina del Rey, CA - BioDiscovery, Inc., a leading developer of software solutions for microarray research, announced today a distribution agreement with UBI. Under terms of the agreement, UBI will distribute CloneTracker, ImaGene, and GeneSight. These are BioDiscovery's industry leading desktop solutions for setup, image and data analysis of microarrays.

"UBI has proven expertise in selling and supporting bioinformatics software and we believe this expertise will provide direct benefits to Canadian microarray users", stated Greg Moore, Vice President of Business Development and Marketing for BioDiscovery. Lindsay Moir, President of UBI, said, We were looking for best in class microarray image and data analysis technology. BioDiscovery is one of the most mature and successful companies in this growing market. We look forward to providing BioDiscovery microarray software solutions to our rapidly expanding customer base in Canada."

About BioDiscovery:
BioDiscovery offers a complete suite of software products for the entire microarray workflow, to provide a complete, seamless flow of data through array layout, automated image analysis, and statistically robust data analysis. Additional information can be found at http://www.biodiscovery.com

About UBI:
Established in 2001, UBI is the only Canadian company that specializes in the distribution of bioinformatics software. UBI focuses on finding solutions to its customers needs and also provides training, integration and consulting services. As UBI builds its relationships with its suppliers and customers, UBI looks for collaborative development opportunities to build high value software products that provide simple, elegant solutions to meet its customers bioinformatics needs. Additional information can be found at http://www.ubi.ca
\